{"data":[{"accessionNo":"0002012383-26-003714","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001635088","issuerName":"ROIVANT SCIENCES LTD","ticker":"ROIV","cusip":"G76279101","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":59285183,"percentOfClass":8.2,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000895421-26-000250","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":"G76279101","securityClass":"Common Shares","eventDate":"2026-06-30","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":40693386,"percentOfClass":5.7,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000895421-26-000250","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":"G76279101","securityClass":"Common Shares","eventDate":"2026-06-30","reportingPerson":"Morgan Stanley Investment Management Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":39432015,"percentOfClass":5.5,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000895421-26-000174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":"G76279101","securityClass":"Common Shares","eventDate":"2026-03-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":49473835,"percentOfClass":6.9,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000895421-26-000174","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":"G76279101","securityClass":"Common Shares","eventDate":"2026-03-31","reportingPerson":"Morgan Stanley Investment Management Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":48260685,"percentOfClass":6.7,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0002007997-26-000001","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":"G76279101","securityClass":"Common Shares","eventDate":"2026-03-31","reportingPerson":"Ramaswamy Vivek","reportingCik":null,"personType":"IN","sharesOwned":25534970,"percentOfClass":3.6,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000102909-26-002262","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd","ticker":"ROIV","cusip":"G76279101","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000315066-26-000652","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001635088","issuerName":"ROIVANT SCIENCES LTD","ticker":"ROIV","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":73641253.25,"percentOfClass":10.3,"filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000315066-26-000652","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001635088","issuerName":"ROIVANT SCIENCES LTD","ticker":"ROIV","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":73641253.25,"percentOfClass":10.3,"filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001493152-26-007176","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, par value $0.0000000341740141 per share","eventDate":"2025-12-31","reportingPerson":"SB Investment Advisers (UK) Limited","reportingCik":null,"personType":"CO","sharesOwned":16413603,"percentOfClass":2.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001493152-26-007176","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, par value $0.0000000341740141 per share","eventDate":"2025-12-31","reportingPerson":"SoftBank Vision Fund L.P.","reportingCik":null,"personType":"PN","sharesOwned":16413603,"percentOfClass":2.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001493152-26-007176","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, par value $0.0000000341740141 per share","eventDate":"2025-12-31","reportingPerson":"SVF Holdings (UK) LLP","reportingCik":null,"personType":"PN","sharesOwned":16413603,"percentOfClass":2.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001493152-26-007176","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, par value $0.0000000341740141 per share","eventDate":"2025-12-31","reportingPerson":"SVF Investments (UK) Limited","reportingCik":null,"personType":"CO","sharesOwned":16413603,"percentOfClass":2.3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001635075-26-000001","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Ramaswamy Vivek","reportingCik":null,"personType":"IN","sharesOwned":48428792,"percentOfClass":6.8,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000895421-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":55491570,"percentOfClass":8,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000895421-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Morgan Stanley Investment Management Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":54403260,"percentOfClass":7.8,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000315066-26-000521","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001635088","issuerName":"ROIVANT SCIENCES LTD","ticker":"ROIV","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":65779463.77,"percentOfClass":9.5,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000315066-26-000521","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001635088","issuerName":"ROIVANT SCIENCES LTD","ticker":"ROIV","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":65779463.77,"percentOfClass":9.5,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001493152-25-023531","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, par value $0.0000000341740141 per share","eventDate":"2025-09-30","reportingPerson":"SB Investment Advisers (UK) Limited","reportingCik":null,"personType":"CO","sharesOwned":40315127,"percentOfClass":5.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001493152-25-023531","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, par value $0.0000000341740141 per share","eventDate":"2025-09-30","reportingPerson":"SVF Investments (UK) Limited","reportingCik":null,"personType":"CO","sharesOwned":40315127,"percentOfClass":5.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001493152-25-023531","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, par value $0.0000000341740141 per share","eventDate":"2025-09-30","reportingPerson":"SVF Holdings (UK) LLP","reportingCik":null,"personType":"PN","sharesOwned":40315127,"percentOfClass":5.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0001493152-25-023531","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, par value $0.0000000341740141 per share","eventDate":"2025-09-30","reportingPerson":"SoftBank Vision Fund L.P.","reportingCik":null,"personType":"PN","sharesOwned":40315127,"percentOfClass":5.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":null,"personType":"PN","sharesOwned":23594831,"percentOfClass":3.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":23594831,"percentOfClass":3.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Ott David C.","reportingCik":null,"personType":"IN","sharesOwned":23594831,"percentOfClass":3.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":23594831,"percentOfClass":3.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Equities Master Ltd.","reportingCik":null,"personType":"CO","sharesOwned":12254313,"percentOfClass":1.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"VIKING GLOBAL PERFORMANCE LLC","reportingCik":null,"personType":"OO","sharesOwned":12504401,"percentOfClass":1.8,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Opportunities GP LLC","reportingCik":null,"personType":"OO","sharesOwned":6238704,"percentOfClass":0.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Opportunities Illiquid Investments Sub-Master LP","reportingCik":null,"personType":"PN","sharesOwned":6238704,"percentOfClass":0.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Opportunities Parent GP LLC","reportingCik":null,"personType":"OO","sharesOwned":6238704,"percentOfClass":0.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Opportunities Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":6238704,"percentOfClass":0.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Viking Long Fund Master Ltd.","reportingCik":null,"personType":"CO","sharesOwned":4851726,"percentOfClass":0.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Viking Long Fund GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4851726,"percentOfClass":0.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"},{"accessionNo":"0000905148-25-004064","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001635088","issuerName":"Roivant Sciences Ltd.","ticker":"ROIV","cusip":null,"securityClass":"Common Shares, $0.0000000341740141 par value per share","eventDate":"2025-09-30","reportingPerson":"Viking Global Equities II LP","reportingCik":null,"personType":"PN","sharesOwned":250088,"percentOfClass":0.04,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/roiv"}],"updatedAt":"2026-10-29T06:59:41.909Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/roiv","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}